12:00 AM
 | 
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Olesoxime: Completed Phase Ib enrollment

Trophos completed enrollment of 44 patients with stable RRMS receiving interferon (IFN) beta in the double-blind, placebo-controlled, French Phase Ib Translate MS-Repair trial...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >